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Penemuan Projek/Abstrak 
(Perlu disediakan makluman di an tara 100 - 200 perkataan di dalam Bahasa Malaysia dan Bahasa 
lnggeris. lni kemudiannya akan dimuatkan ke dalam Laporan Tahunan Sahagian Penyelidikan & 
Pembangunan sebagai satu cara untuk menyampaikan dapatan projek tuan/puan kepada pihak 
Universiti). 
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(b) Senaraikan Kata Kunci yang digunakan di dalam abstrak: 
Bahasa Malaysia Bahasa lnggeris 
Sel-sel endothelium kornea Cornea endothelial cells 
Bahan viskoelastik Viscoelastic agents 
Pembedahan phakoemulsifikasi Phacoemulsification surgery 
Ketumpatan sel-sel Cells density 
Purata saiz sel Average cell size 
Variasi koeffisi saiz sel Coefficient variation of the cell size 
Hexagonaliti sel Hexagonality 
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ABSTRACT 
Objective: To compare corneal endothelial morphological changes after the use of 
Healon 5 (sodium hyaluronate 2.3%) and Healon GV (sodium hyaluronate 1.4%) during 
phacoemulsification surgery, particularly at three months after the surgery. 
Settings: Department of Ophthalmology, School of Medical Sciences, Universiti Sains 
Malaysia, Malaysia and Eye clinic, Hospital Kota Bharu, Kelantan, Malaysia. 
Materials and Methods: One hundred and ten patients were randomized, 55 per group, 
in a prospective randomized clinical trial of phacoemulsification surgery using Heal on 5 
or Heal on GV. Three ophthalmologists performed the surgeries. The corneal endothelial 
cells density, average cell size, coefficient variation and hexagonality were assessed 
preoperatively and at three months postoperatively using a non-contact specular 
microscope Topcon SP2000P. Analysis of the data was performed using SPSS version 
10.0, Independent-Samples T Test. 
Results: There was statistically significant difference between Healon 5 group and 
Healon GV group based on endothelial cell density (p=0.015) and percentage of cell loss 
(p=0.033). The cell size was noted significantly smaller in the Healon 5 group compared 
to the Healon GV group at three months (p=0.004). A similar result was also noted in 
percentage of changes in cell size (p=0.033). There were no statistically significant 
differences in changes of coefficient variation of cell size and hexagonality in both 
groups at three months after the surgery. 
Conclusion: Minimal corneal endothelial morphological changes were noted in the 
Healon 5 group compared to the Healon GV group, particularly in term of less cell loss 
and less alteration in cell size at three months after the surgery. Thus, indicates that 
Healon 5 is more effective than Healon GV in minimizing risk of corneal endothelial 
injury during phacoemulsification surgery. 
KEYWORDS 
phacoemulsification surgery, endothelial morphology, viscoelastic substances 
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INTRODUCTION 
Phacoemulsification surgery was first introduced by Dr Charles Kelman in 1967 with 
numerous convincing outcomes; such as small incision surgery, improving astigmatism 
and leading to a faster recovery period 1• The evolution of cataract surgery techniques and 
instrumentations started changing thereafter. Despite this promising outcome, the 
endothelial cell loss due to phacoemulsification surgery becomes a major concern among 
the ophthalmologists world wide. 
Ophthalmic viscosurgical devices (OVDs) are the most commonly used tool in modem 
cataract surgery mainly to protect the corneal endothelium from mechanical and surgical 
trauma2-3• Secondly, they also maintain anterior chamber depth during cataract surgery.2-3 
Therefore, they facilitate the surgery, minimize trauma to the corneal endothelium and 
reduce the amount of endothelial loss in anterior segment surgery, particularly cataract 
_.2-3 
surgery . 
Healon GV (sodium hyaluronate 1.4%, Pharmacia) was introduced into the market in 
1993. Its cohesive property made manipulation of anterior and posterior tissues much 
easier. Healon 5 (sodium hyaluronate 2.3%, Pharmacia) became available 5 years later 
and claimed to be the first of new generation of more versatile viscoelastic agents 
designed specifically for phacoemulsification. It actually exhibits both cohesive and 
dispersive properties. In low flow settings during capsulorhexis and lens implantation, 
Healon 5 behaves a cohesive property and maintains space better than previously 
3 
available viscoelastic4 • While in high flow settings used in modem phacoemulsification, 
such as chopping, cracking and supercapsular phaco, it displays a dispersive property
4
• 
Argument and discussion regarding advantages and disadvantages of Healon 5 and 
Healon GV are very interesting, mainly upon their protective behavior on cornea 
endothelial cells during the surgery. Endothelial cell density and other morphological 
changes, i.e. cell size, coefficient variation of cell size and hexagonality are important 
parameters to reflect the state of endothelial cells. 
However to our knowledge, there is no single study yet that evaluates the morphological 
changes of endothelial cells, particularly regarding changes in cells density, average cell 
size, coefficient variation and hexagonality pertaining to Healon 5 and Healon GV in 
phacoemulsification surgery. We believe that there is a need to confirm the overall 
morphological change of the corneal endothelium after phacoemulsification surgery, 
particularly using Healon 5 and Healon GV as the viscoelastic substances 
intraoperatively. 
This study aimed to compare corneal endothelial morphological changes (i.e. cell density, 
cell size, coefficient of variation in cell size and hexagonality) after use of Heal on 5 and 
Healon GV at three months after phacoemulsification surgery. 
4 
MATERIALS AND METHODS 
This randomized clinical trial was conducted between 1st January 2003 till 281h February 
2004 at the Eye Clinic, Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan and 
Eye Clinic, Hospital Kota Bharu, Kelantan, Malaysia. The study protocol was approved 
by the Research and Ethical Committee, School of Medical Sciences, Universiti Sains 
Malaysia. A minimum of hundred and ten patients were required for this study based on 2 
mean formula. 55 patients recruited into Healon 5 group and another 55 patients into 
Healon GV group using a sealed envelope technique. 
Patients of either sex who were 40-75 years old, age related cataract, normal intraocular 
pressure, axial length of eyeball between 22-26 mm, baseline endothelial count more than 
2000 cells/mm2 and underwent uncomplicated phacoemulsification surgery with posterior 
chamber intraocular lens implantation were included. 
Patients were excluded if they had endothelial cell disease, glaucoma, uveitis, previous 
ocular trauma/surgery, intraoperative complications e.g. posterior capsule rupture, 
vitreous loss, anterior chamber lens implantation etc. and post operative complications 
e.g. raised intraocular pressure, hyphema etc. Patients with systemic illnesses that would 
compromise endothelial cell function e.g. diabetes mellitus, chronic renal failure and 
chronic obstructive airway disease were also excluded. 
5 
All potential patients underwent a complete ocular and systemic assessment at two weeks 
before the surgery (pre-op assessment) in both centers. A thorough ocular and systemic 
history was taken. Visual acuity of both eyes was tested with the standard 
retroilluminated Snellen Chart. Proper examinations of both anterior segment and 
posterior segment were performed to look for any apparent ocular abnormalities. Lens 
density was graded using Emery's Classification based on combination of opalescence 
and yellowing of nuclear sclerosis5. A complete systemic examination and baseline 
investigations that include electrocardiograph, full blood count, random blood sugar and 
serum electrolytes were performed to rule out systemic illness. 
Selection of patients was made on the admission day by two co-investigators in both 
centers respectively. Written informed consents were taken from the patients. The 
baseline central corneal endothelial photomicrograph was performed. Endothelial 
morphology was measured using a non-contact Topcon SP2000P specular microscope. 
All the patients would be randomized using envelope technique. A stack of opaque 
envelopes was prepared earlier with 55 envelopes containing a piece of paper with the 
word 'Healon 5' and the remaining 55 envelopes stated 'Healon GV'. These envelopes 
were shuffled and stored at the randomization room in Hospital Universiti Sains 
Malaysia. The envelope was drawn for each patient. The ophthalmic viscoelastic device 
would be assigned during the phacoemulsification surgery based on the printed paper 
selected for every patient. 
6 
All the patients were admitted to the respective centers for elective phacoemulsification 
and intraocular lens implantation. The surgeries had been performed by experienced 
phacoemulsification surgeons. There were two surgeons in Hospital Universiti Sains 
Malaysia and one surgeon in Hospital Kota Bharu, Kelantan involved in this study. 
On the operative day, the pupillary dilatation was accomplished with 2.5% 
phenylepinephrine and 1% tropicamide. This was done at one hour before the surgery. 
Lid speculum was inserted to separate the eyelids. Subtenon anaesthesia (Lignocaine and 
Marcaine ratio was 1:1) was administered to every patient. Standard phacoemulsification 
surgeries were performed in all patients. Limbal scleral- tunnel incision was made at 12 
o'clock using a 3.5 mm phaco knife. A side port was established to allow the entry of a 
nucleus rotator (second instrument) at 2.30 o'clock position. Next, the assigned 
viscoelastic device was injected into the anterior chamber. A continuous curvilinear 
capsulorhexis was made. Lens nucleus and cortex were hydrodissected with balanced salt 
solutions. The nucleus was removed using phacoemulsification technique. After the 
remaining lens cortex was removed with an irrigation/aspiration (II A) probe, the anterior 
chamber and capsular bag were expanded with the remaining viscoelastic device. A 
foldable acrylic intraocular lens was then implanted in the capsular bag. The viscoelastic 
material was removed using the irrigation/aspiration (II A) probe. The incision was left 
either sutureless (stromal hydration) or sutured with 10/0 nylon to a maximum of three 
stitches. 
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As Healon 5 and Healon GV were packed in distinctive syringes and had distinctive 
handling characteristics (Table 1), it was not possible to mask the surgeons to the device 
used. Throughout the surgery, the surgeons were allowed to use one vial of viscoelastic 
material only. Patients who required more than one vial of viscoelastic intraoperatively 
would be excluded from the study. Pupillary size, type of viscoelastic agent used, 
ultrasound time, phaco power and duration of the procedure were documented in the 
study fonns. 
Postoperatively, all patients in both centers were prescribed oral acetazolamide 250 mg 
three times daily for a day. After being reviewed on day one postoperatively, they were 
discharged home with prednisolone acetate l% ophthalmic solution two hourly for a 
week, tapered to four hourly for a month and six hourly for another one month. All 
patients were examined postoperatively at their respective centers; at one week, one 
month and three months after the surgery and had their cornea endothelial 
photomicrograph at three months postoperatively. 
The endothelial morphology analysis was done by the principal investigator in Hospital 
Universiti Sains Malaysia using the lMAGEnet 2000, cell analysis software (version 
2.11 ). The endothelial cells density, average cell size, coefficient of variation in cell size 
and the percentage of hexagonal cells were analyzed using a traced method6• To improve 
accuracy, we standardized to minimum of I 00 cells required for a baseline data 
1 . 7 ana ys1s . 
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All the statistical analysis was done with Statistical Package for Social Sciences (SPSS 
Inc) software, version 1 0.0. Normality was tested using Eye-balling (histogram pattern). 
In a normally distributed data, difference of means between the two groups were tested 
with an Independent Sample T -test (p=0.05). While in skewed data, difference of means 
between the two groups were tested with Mann-Whitney U test (p=0.05). 
Table 1. Physical and biochemical properties comparing Healon 5 and Healon GV 
Physical I Biochemical Healon 5 Healon GV 
properties 
Storage (C) 2-8 2-8 
Ingredients/ ml 23 mgNaHa 14mgNaHa 
Concentration ( % ) 2.3 1.4 
Viscosity (mPas) 7 000 000 2 000 000 
Osmolarity (mosm/L) 309 302 
Molecular weight (Dalton) 4 000 000 5 000 000 
pH value 7.0-7.5 7.0-7.5 
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RESULTS 
There were no statistically significant differences between Healon 5 group and Healon 
GV group before surgery with regards to age and nucleus density (p>0.05). We found 
there were no statistically significant differences regarding phaco time and phaco power 
intraoperatively between the two groups (p>0.05). 
The mean endothelial cell parameters preoperative and postoperativeiy were illustrated in 
Table 2. These include endothelial cell density, average cell size, coefficient variation of 
cell size and hexagonality. 
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Table 2. Outcome variables. 
Endothelial density ( cells/mm2) 
Preoperative 
3 months postoperative 
Changes(%) 
Average cell size (J.Lm2) 
Preoperative 
3 months postoperative 
Changes(%) 
Coefficient of variation in cell 
size 
Preoperative 
3 months postoperative 
Changes(%) 
Hexagonality (%) 
Preoperative 
3 months postoperative 
Changes(%) 
* p-value < 0.05 (significant) 
Independent-Samples T Test 
Healon 5 
(n=55) 
2529.73 ± 301.73 
2279.58 ± 395.63 
9.8 
385.85 ± 43.05 
446.29 ± 87.02 
15.6 
39.84 ± 6.52 
40.26 ± 4.92 
1.1 
51.39 ± 6.48 
46.87 ± 7.77 
8.8 
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Healon GV p value 
(n=55) 
2504.09 ± 306.64 0.174 
2067.86 ± 439.80 0.015 
17.4 0.033 
403.11 ± 54.68 0.069 
511.61 ± 61.67 0.004 
26.9 0.033 
38.30 ± 5.83 0.181 
40.22 ± 7.16 0.973 
5.0 0.261 
50.82 ± 6.71 0.652 
44.25 ± 7.93 0.083 
12.9 0.120 
DISCUSSION 
Endothelial cell loss is an indicator of permanent injury to the cornea. When endothelial 
cells die and drop out, adjacent cells expand to fill the gaps created in order to keep the 
Descemet's membrane remains covered. As a result, the endothelial cells densities 
decrease and mean cells size increase. Severe degree of trauma will lead to pleomorphism 
and polymegathism. The resulting changes are secondary indicator of cornea endothelial 
injury. 
We studied the difference of cell density, average cell size, coefficient of variation in cell 
size and hexagonality at three months postoperative period. The endothelial cells sustain 
variable degree of injury following phacoemulsification surgery. An adequate time needs 
to be given for the cells to recover and reorganize. The endothelial cells were reported to 
stabilize and reorganize at least at three months post operative period8• 
There was a statistically significant difference in cell density and percentage of cell loss 
between the Healon 5 group and the Healon GV group at three months after the surgery. 
This finding suggested that Healon 5 was better than Healon GV in preserving 
endothelial cell density during phacoemulsification surgery. 
This result is consistent with a study conducted by Holzer et al in 2001 9. They randomly 
assigned eighty one eyes to receive one of five viscoelastic agents which were Healon 5 
' 
Heal on GV, Visco at, Ocucoat and Celoftal during phacoemulsification. They found that 
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the Healon 5 group had the lowest mean endothelial cell loss (6.2%), significantly lower 
that in the other groups. Mean cell loss was 10.9% in the Healon GV group, 12.9% in the 
Celoftal group, 15.4% in the Viscoat group and 16.7% in the Ocucoat group. 
We reported a slightly higher percentage of cell loss as compared to the Holzer et al 
(2001). In our study, the amount of cell loss in the Healon 5 group was 9.8% and 17.4% 
in the Healon GV group compared to 6.2% in the Healon 5 group and 10.9% in the 
Healon GV group as reported by Holzer et al. 
Multiple surgeon involvement and differences in their techniques could be the main 
confounding factor in our study. We agreed that they definitely had some differences in 
their skills of performing phacoemulsification surgery though they were experienced 
surgeons. In contrast to Holzer et al (2001), there was only single surgeon involved who 
performed similar technique in all the patients. 
The surgeon's technique was another major contributing factor to the above result. 
Pirazzoli et al in 1996 reported that there was increased endothelial cell loss with divide 
and conquer technique (13.8%) compared to phaco and chop technique (4.72%)10. In our 
study, two surgeons performed divide and conquer technique while one surgeon preferred 
phaco and chop technique. In contrast to Holzer et al (200 1 ), the surgeon performed 
phaco and chop technique in all studied patients. 
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We found that the average cell size and the changes of average cell size at three months 
after the surgery were statistically significant. Again, this observation suggested that 
Heal on 5 was better than Healon GV in preserving the endothelial cell size. 
We found no statistical differences between the Healon 5 and Healon GV groups with 
regards to changes in percentage of coefficient variation and hexagonality of the cells at 
three months postoperative period. This phenomenon was probably because all the cases 
included in this study were actually had uncomplicated phacoemulsification surgery for 
age related cataract only. We had excluded earlier patients with small pupil diameter11 , 
shorter axial length 12, past history of trauma, compromised endothelial cell function, 
uveitis13, glaucoma14, known systemic disorder15-16 and with intra or postoperative 
complications who were at higher risk of developing severe injury to the endothelial cells 
following phacoemulsification surgery. 
We do believe that the viscoadaptive property of Heal on 5 will be more beneficial in the 
difficult cases, as mentioned above. Perhaps the above two variables will display a 
statistically significant outcome if they are being assessed in complicated cases which 
require more surgical manipulations. However, another prospective randomized study is 
needed to prove this theory. 
This result also agrees with a study by Koch et al in 1993 as they found no statistically 
significant differences between the Healon and Viscoat groups with respect to changes in 
percentage of hexagonality and coefficient variation after posterior chamber 
14 
phacoemulsification at four months after the surgery. However, they demonstrated 
significant increased in coefficient of variation and decreased in hexagonality in Viscoat 
group that underwent iris-plane phacoemulsification compared to Viscoat group, whom 
had posterior chamber phacoemulsification surgery17• 
This finding suggested that the coefficient variation and hexagonality were actually less 
sensitive indicators in assessing the degree of endothelial damage. The endothelial cells 
need to sustain a greater degree of trauma, thus the above two variables will show a 
significant difference. 
There are many other factors predispose to cornea endothelial damage during 
phacoemulsification surgery. Apart from factors mentioned above, the other confounding 
factors include age18, density of the nucleus 11 , phacoemulsification time and power19• In 
this study, we found no statistically significant differences of these parameters between 
both Healon 5 and Healon GV groups. We also standardized steps of cataract surgery 
including wound size19, site20 and method of lens insertion21 as they might predispose to 
the endothelial cells injury during phacoemulsification surgery. 
Dick et al ( 1996) reported that wound size influenced the risk of endothelial loss and 
injury19· We performed a 3.5 mm comeoscleral wounds with the aim of minimizing 
endothelial damage in relation to wound size and site. Beltrame et al (2002) reported that 
as it was placed more posteriorly, comeoscleral wound caused minimal trauma as 
compared to clear corneal incision20 • Levy et al (1988) reported that flat insertion 
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technique caused 7.7% cell loss compared to 14.3% loss with forcep technique and 
16.9% loss with syringe-style insertion technique21 • Choice oflocal anaesthesia
22
, amount 
of irrigating solutions23 and sutureless versus few stitches
24 
used were reported that did 
not cause significant influence to the endothelial cells. 
As a conclusion, we would like to state that Healon 5 is generally superior to Healon GV 
during uncomplicated phacoemulsification surgery. It preserves cornea endothelial 
morphology mainly the cells density and the average cell size. Thus, we would like to 
suggest usage of Healon 5 in cataract surgery especially in complicated cases, diseased 
corneas and patients with pre-existing endothelial morphological changes. 
16 
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ABSTRAK 
Objektif: Untuk membandingkan perbezaan morfologi pada sel-sel endothelium kornea 
selepas pembedahan phakoemulsifikasi menggunakan 'Healon 5' (2.3% 'sodium 
hyaluronate') dan 'Heaton GV' (1.4% 'sodium hyaluronate'), iaitu pada bulan ketiga 
selepas pembedahan. 
Methodologi: Seratus sepuluh orang pesakit dibahagikan secara rambang kepada dua 
kumpulan iaitu 55 pesakit setiap kumpulan menggunakan 'Healon 5' atau 'Heaton GV' 
semasa pembedahan phakoemulsifikasi. Tiga pakar oftalmologi telah melakukan 
pembedahan-pembedahan ini secara berasingan. Kepadatan sel, purata saiz sel, variasi 
koeffisien dan peratus hexagonal telah dicatatkan sebelum pembedahan dan pada bulan 
ketiga selepas pembedahan. Prosedur ini dilakukan dengan menggunakan milcroskop 
spekular tanpa sentuh (Topcon SP2000). Analisis data telah dilakukan menggunakan 
'SPSS versi 1 0.0, Independent-Samples T Test'. 
Keputusan: Terdapat perbezaan yang signifikan secara statistik diantara kumpulan 
'Healon 5' dan kumpulan 'Heaton GV' berdasarkan kepadatan sel (p=O.Ol5) dan 
peratusan kehilangan sel-sel endothelium (p=0.033). Didapati saiz sel endothelium 
komea mengalami perbezaan yang signifikan secara statistik diantara kumpulan 'Healon 
5' dan kumpulan 'Heaton GV' (p=0.004) pada bulan ketiga selepas pembedahan. 
Keputusan yang serupa juga dilihat melibatkan peratusan perubahan saiz sel (p=0.033). 
IV 
Tidak terdapat sebarang perbezaan yang signifikan secara statistik berdasarkan perubahan 
variasi koeffisien saiz sel dan peratus hexagonal diantara kedua-dua kumpulan 
dicatatkan. 
Kesimpulan: Terdapat perubahan morfologi sel-sel endothelium komea yang minimum 
didalam kumpulan 'Healon 5' berbanding kumpulan 'Healon GV', terutamanya didalam 
kehilangan sel-sel dan perubahan saiz sel-sel pada bulan ketiga selepas pembedahan. Ini 
bennalma, 'Heal on 5' adalah Iebih berkesan berbanding 'Heal on GV' bagi 
mengurangkan risiko kecederaan pada sel-sel endothelium kornea semasa pembedahan 
katarak secara phakoemulsifikasi. 
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ABSTRACT 
Objective: To compare corneal endothelial morphological changes after the use of 
Healon 5 (sodium hyaluronate 2.3%) and Heaton GV (sodium hyaluronate 1.4%) during 
phacoemulsification surgery, particularly at three months after the surgery. 
Methodology: One hundred and ten patients were randomized, 55 per group, in a 
prospective randomized clinical trial of phacoemulsification surgery using Healon 5 or 
Healon GV. Three ophthalmologists performed the surgeries. The corneal endothelial 
cells density, average cell size, coefficient variation and hexagonality were assessed 
preoperatively and at three months postoperatively using a non-contact specular 
microscope Topcon SP2000. Analysis of the data was performed using SPSS version 
1 0.0, Independent-Samples T Test. 
Result: There was statistically significant difference between Healon 5 group and 
Healon GV group based on endothelial cell density (p=O.OlS) and percentage of cell loss 
(p=0.033). The cell size was noted significantly smaller in the Healon 5 group compared 
to the Healon GV group at three months (p=0.004). A similar result was also noted in 
term of percentage of changes in cell size (p=0.033) . 
There were no statistically significant differences in changes of coefficient variation of 
cell size and hexagonality in both groups at three months after the surgery. 
VI 
Conclusion: Minimal corneal endothelial morphological changes were noted in the 
Heaton 5 group compared to the Heaton GV group, particularly in term of less cell loss 
and less alteration in cell size at three months after the surgery. Thus, indicates that 
Heaton 5 is more effective than Healon GV in minimizing risk of corneal endothelial 
injury during phacoemulsification surgery. 
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1. INTRODUCTION 
1.1 BACKGROUND 
Phacoemulsification surgery was first introduced by Dr Charles Kelman in 1967 with 
numerous convincing outcomes; such as small incision surgery, improving 
astigmatism and leading to a faster recovery period. The evolution of cataract surgery 
techniques and instrumentations started changing thereafter. Despite this promising 
outcome, the endothelial cell loss due to phacoemulsification surgery becomes a 
major concern among the ophthalmologists world wide. 
Ophthalmic viscosurgical devices (OVDs) are the most commonly used tool in 
modem cataract surgery mainly to protect the corneal endothelium from mechanical 
and surgical trauma. Secondly, they also maintain anterior chamber depth during 
cataract surgery. Therefore, they facilitate the surgery, minimize trauma to the corneal 
endothelium and reduce the amount of endothelial loss in anterior segment surgery, 
particularly cataract surgery. 
Both Heaton 5 and Healon GV were recently introduced into ophthalmic use and has 
become an important tool in phacoemulsificarlon surgery. However, argument and 
discussion regarding their advantages and disadvantages are very interesting, mainly 
upon their protective behavior on cornea endothelial cells during the surgery. 
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There were few studies evaluating the amount of central endothelial loss after 
phacoemulsification surgery between Healon 5 with other ophthalmic viscosurgical 
device(s) or Healon GV with other ophthalmic viscosurgical device(s) had been 
published. 
There was a study conducted by Holzer et al in 2001, comparing the effect ofHealon 
5 and other four viscoelastic substances (i.e. Ocucoat, Celoftal, Viscoat and Healon 
GV) on the corneal endothelium after cataract surgery. The variable assessed in this 
study was mainly the endothelial cell count, which was performed preoperatively and 
90 days postoperatively. They did not evaluate other indicators of endothelial damage 
including cell size, changes in coefficient variation or hexagonality of the cells. Their 
conclusion was that the Healon 5 group had the lowest mean endothelial cell loss 
(6.2%) compared to Healon GV group (10.9%). The other groups have a bigger 
percentage of loss; Celoftal12.9%, Viscoat 15.4% and Ocucoat 16.7%. 
A fairly similar study to ours was conducted by Miller et al in 1999. They compared 
the protective effect of Heal on GV and Viscoat to the corneal endothelium following 
pbacoemulsification surgery. They analyzed average endothelial cell size and density 
before and at two weeks after phacoemulsification surgery. The power of their study 
was sufficient (80%) to confirm a statistically significant mean difference between 
Healon GV and Viscoat. There were no significant differences in endothelial cell size 
and density between the two groups. Thus, they concluded that both Healon GV and 
3 
Viscoat were comparable in their ability to protect the corneal endothelium during 
phacoemulsification surgery. 
The protective effect of Heal on 5 had been compared with Heal on recently by Oshika 
et al in 2004. However, the variables assessed were different from our study. They 
studied the cell count and corneal thiclmess before and at one day, one week and three 
months after the phacoemulsification surgery. They found that both Healon 5 and 
Healon had no statistically significant difference in cell count and thiclmess, which 
implied that both had equal rate of protection on the corneal endothelium during 
phacoemulsification surgery. 
However to our knowledge, there is no single study yet that evaluates the 
morphological changes of endothelial cells, particularly regarding changes in cell 
size, coefficient variation, cells density and hexagonality pertaining to Healon 5 and 
Healon GV in phacoemulsification surgery. 
We believe that there is a need to confirm the overall morphological change of the 
corneal endothelium after phacoemulsification ~surgery, particularly using Healon 5 
and Healon GV as the viscoelastic substances intraoperatively. Thus, we conducted a 
prospective, randomized, patient and observer masked study to evaluate the above 
changes. We do hope that the outcome of this study will provide a better 
understanding of their role in future cataract surgery. 
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1.2 CORNEA 
1.2.1 ANATOMY OF THE CORNEA 
Cornea is the clear transparent tissue comprising the central one sixth of the globe. It 
occupies the center of anterior pole of the globe. Since the sclera and conjunctiva 
overlap the cornea anteriorly, slightly more above and below than medially and 
laterally, the cornea appear elliptical when viewed from the front. In adult it measures 
about 12 mm in the horizontal meridian and about 11 nun in the vertical meridian. 
Based on the histological criteria, cornea can be divided into five layers; superficial 
epithelial layer, Bowman's membrane, cornea stroma, Descemet's membrane and the 
innermost endothelium layer. The epithelium consists of non keratinized stratified 
squamous epithelium, which is five to seven layers thick at the centre of the cornea. 
The thiclrness is approximately 500 to 550 micrometer. Bowman's layer is fonned by 
the condensation of anterior stroma, located just beneath the epithelial basement 
membrane. The stroma makes up almost 90% of the total cornea thiclmess. It consists 
of78% water, 20% protein and 1% glycosaminoglycan. Descemet's membrane is thin 
layer that is actually formed by the cornea endothelial basement membrane. 
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1.2.2 FUNCTION OF THE CORNEA 
The cornea is the most important refractive medium in the eye. This refractive power 
occurs on the anterior surface of the cornea, where the refractive index of the cornea 
(1.38) is greatly different from that of the air. Tear film is very crucial in maintaining 
the normal environment for the corneal epithelial cells. 
The transparency of the cornea results from uniform spacing of the collagen fibrils in 
the substantia propria. Any increase in tissue fluid between the fibrils causes 
cloudiness of the cornea. The endothelial cells play a major role in limiting fluid 
uptake by the cornea stroma. This mechanism most probably occurs as the result of 
both its barrier function and most important, its active transport function. 
If the above mechanism fails as a result of trauma or disease, the stroma loose its' 
dehydration state and present clinically as corneal oedema. Thus, this will eliminate 
the transparency property of the cornea. 
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1.3 CORNEA ENDOTHELIUM 
The cornea endothelium is derived from the embryonic neural crest cells. It is a single 
layer of predominantly hexagonal cells that completely covers the posterior cornea 
surface. At birth, the endothelial cell density is approximately 4000 cells/mm2• The 
density then rapidly falls over the first two years of life. This is mainly due to the 
rapid cornea growth and subsequent larger surface area of the posterior cornea. At the 
age of 20 years, the density is about 3500 celllmm2• This reduces further to about 
2000 celllmm2 in the eighth to ninth decades of life. 
The American Academy of Ophthalmology (1991) reported that cornea with an 
endothelial density between 2000 and 1000 cells/mm2 are susceptible to 
decompensation. Those with density of less than 1000 cells/mm2 are more 
susceptible to surgical trauma. 
A minimum level of 400 to 700 cells/mm2 is required for maintenance of normal 
corneal function. This was clearly demonstrated by Bourne et al in 1976 who studied 
corneal endothelial morphology on healthy and tliseased corneas of human volunteers 
soon after the introduction of specular microscopy. If the above critical number was 
not attained, the pumping and barrier function ceased. This would result 1n 
irreversible cloudiness and corneal decompensation with bullous keratopathy. 
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The absolute cell density is not the only sole determinant of endothelial health and 
physiological function. Endothelial health is also influenced by cell morphology. 
Thus, to accurately describe the endothelium health and function, it is useful to look 
at other variables such as cell size, variation of cell size in term of 'coefficient of 
variation' (CV) and variation of endothelium shape in terms of 'hexagonality'. 
Cell size is determined by measuring the areas between the apical membranes. A 
population based study by Padilla et a1 in 2004 among healthy Filipinos revealed that 
the mean cell size was 363.0 J..Lm. An increased in cell size usually occurs following 
surgery especially during early postoperative period and this signifies degree of 
damage to the endothelium. 
Coefficient of variation (CV) shows degree of uniformity of the cell size within the 
whole endothelium population (standard deviation of cell area/ mean cell area). It 
provides a quantitative measurement of cell variation. Another population based 
study by Snellingen et al in 2001 suggested a mean coefficient variation of 37.8% 
among senile cataract patients, aged 40-75 years old in South Asia population. An 
increase in this value indicates high variability of cell size, known as 
'polymegathism'. Increases in coefficient of variation in cell size signify a decrease in 
unifonnity of cell size and indicate certain degree of endothelial injury. 
Generally, over 60 % of the cells have a hexagonal shape as documented earlier by 
Yee at ai (1985). However, a slightly difference data was demonstrated in South Asia 
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population by Snellingen et al (2001). Among 1235 patients in this area of the world, 
aged between 40-75 years old with senile cataract, they found that the mean 
hexagonality was actually 40%. A decreased in this percentage with concomitant 
increase in the number of non hexagonal shape cells is lmown as 'pleomorphism'. 
Having a low percentage of hexagonality or pleomorphism is also another indicator of 
endothelial injury. 
Both the coefficient of variation in cell size and hexagonality are independent of cell 
density. Schultz et al (1984) reported that the coefficient of variation in cell size and 
the hexagonality were inversely related. They noted that there were no significant 
differences of the endothelial cell density both in type I and type II diabetes mellitus 
compared to the age-matched non-diabetic populations. They also demonstrated that 
these patients have a significantly higher coefficient of variation and a decrease in the 
percentage of hexagonal cells. 
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1.3.1 CORNEAL ENDOTHELIUM MORPHOLOGICAL CHANGES IN 
VARIOUS CONDITIONS 
The corneal endothelium can be damaged by a variety of insults, including 
inflammation, increased intraocular pressure, contact lenses, intraocular surgery and 
intracamerally administered pharmaceuticals, for example epinephrine. Systemic 
diseases, for example diabetes, chronic renal failure and chronic obstructive airway 
disease (COAD) are at risk to endothelial cell damage. 
Anterior segment inflammation particularly uveitis, causes significant endothelial 
morphological changes as observed by specular microscopy in various studies. Pillai 
et al in 2000 studied the morphological changes in corneal endothelium in 13 patients 
with unilateral uveitis. They noted a significant difference in mean cell size and 
density in the vicinity of fresh keratic precipitate compared with normal endothelium 
of the opposite eye. However, this abnormal morphology returned to near normal 
values on resolution of uveitis. 
High intraocular pressure is a known factor tot compromise the corneal endothelial 
function. Glaucoma patients are at risk of having endothelial morphological changes. 
This was demonstrated by Sihota et al (2003) who studied the endothelial changes in 
patients with primary angle closure glaucoma. They found a significant decrease in 
the corneal endothelial cell density in eyes with previous attack of acute angle closure 
glaucoma and in eyes with chronic primary angle closure glaucoma. However, there 
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was no further difference of cell density in eyes with subacute attack or the fellow 
eyes in primary angle closure glaucoma as compared to age-matched population. 
An interesting change in endothelium morphology occurs during long term contact 
lens wear. Mac Rae et al (1986) discovered significant degree of pleomorphism and 
polymegathism without cell loss in patients who wore hard or soft contact lens over 
six years or more. Only a little recovery occurred after cessation of hard contact lens 
after four years period. 
Keratoconus is another ocular condition that is associated with corneal endothelial 
morphological changes. Maurice in 1980 found that keratoconus patients had normal 
endothelial cells density but their coefficient variation was significantly high. Their 
percentage of hexagonality also dropped to 50% as compared to age matched 
population. 
Matsuda et al (1984) demonstrated significant endothelial morphological changes in 
the graft following penetrating keratoplasty. Cell density in the graft was often less 
than 1000/mm2• Morphometric analysis showep that the cell loss and increased in 
polymegathism and pleomorphism continued for six months following keratoplasty, 
after which the cornea stabilized. A normal restoration of cell shape, coefficient 
variation and hexagonal pattern were recovered by two years after the surgery. 
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Diabetes mellitus is a known systemic disorder causing significant endothelial 
morphological changes. Schultz et al (1984) demonstrated that in type 2 diabetics 
over ten years or longer duration, their endothelial morphology showed an abnormal 
pattern of analysis. These patients were found to have normal endothelial density but 
high tendency of pleomorphism and polymegathism. Similar changes were also seen 
in type 1 diabetes mellitus. This phenomenon could be explained in relation to 
changes in cellular metabolism. The osmotic effects of sugars perhaps inhibited the 
Na/K pumps and caused alteration in the cell volume regulation. Hence, their 
endothelial cells were less stable and more vulnerable to surgical trauma than in 
nonnal populations. 
Chronic renal failure is another systemic disease known to have alteration in 
endothelial morphological changes. Ohguro et al (1999) studied the corneal 
endothelial morphological changes using a specular microscopy in a 20 patients with 
chronic renal failure patients undergoing hemodialysis. Despite normal endothelial 
density, their corneal endothelium also showed increased percentage of 
pleomorphism and polymegathism. This phenomenon was related to high 
concentration of urea in the aqueous humor. An abnormally high level of oxidized 
glutathione (GSSG) was also noted in the aqueous humor. As the endothelium was 
nourished by the aqueous humor, breakdown in the homeostasis of the aqueous 
humor resulted in endothelial morphology abnormalities in chronic renal failure 
patients. 
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1.3.2 CORNEAL ENDOTHELIAL CHANGES FOLLOWING CATARACT 
SURGERY 
Traditionally, the cataract surgery were perfonned with intracapsular technique and 
subsequently followed with extracapsular technique with intraocular lens 
implantation. In modem surgery, phacoemulsification is currently a preferable 
technique world wide. 
Phacoemulsification with its well-recognized benefits, such as early visual 
rehabilitation, freedom from sutures and ability to permit controlled nuclear removal 
and in-the-bag intraocular (IOL) fixation is currently the most frequently utilized 
technique of cataract removal. However, it is a technique that is highly dependent on 
the utilization of expensive and sophisticated technology. 
Endothelial cell loss is a primary indicator of corneal endothelial injury following 
cataract surgery regardless the type of surgery; intracapsular extraction, extracapsular 
technique or even phacoemulsification sirrgery. When the endothelial cells die and 
drop out, adjacent cells expand to fill the gaps created, so that the Descemet' s 
membrane remains covered. As a result, the endothelial cell densities decrease and 
mean cells size increases. 
The resulting change in average cell size is a secondary indicator of corneal injury. 
Apart from the above, endothelial cell hexagonality and coefficient variation are other 
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common indicators of corneal stress. These parameters also change in response to 
corneal injury. 
Matsuda et a1 in 1984 conducted a study to assess serial alteration in endothelial cell 
shape and pattern after intraocular surgery. They studied the hexagonality changes in 
20 eyes after intracapsular cataract extraction using a computer-assisted digitizer. 
They discovered that during the first one month, the hexagonality significantly 
dropped to a lower level (52%) from the baseline value (68%). Between one to four 
months, the frequency ofhexagonality increased gradually to 64%. 
Increased in coefficient variation and decreased numbers of hexagonal cells occurred 
during the first one month as the cells spread to replace the lost cells. This fact was 
demonstrated earlier by Rao et al in 1978 who studied the morphological changes of 
corneal endothelial following intracapsular cataract extraction surgery. The above 
changes were found usually during early postoperative period and restored close to 
baseline values after a period of time following the surgery. 
A long term observation by Dejaco-Ruhswunn et al in 2002 revealed that continuous 
endothelial cell loss was noted until at four years after posterior chamber lens 
implantation to correct ametropia in thirty four phakic patients. There was a rapid loss 
within one year after the surgery, after which the rate of loss was no longer significant 
thereafter. Despite that, the coefficient of variation and hexagonality remained stable 
during four year follow-up period. 
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1.3.3. RISK FACTORS FOR CORNEAL ENDOTHELIAL INJURY DURING 
PHACOEMULSIFICATION 
These factors had been studied extensively by various researchers ever the first 
introduction of phacoemulsification in the late 1960s. Undoubtedly, the outcome of 
their studies had a great contribution in the improvement of phacoemulsification 
skills, techniques and also the instruments. 
Converting to phacoemulsification technique from other conventional techniques also 
causes a significant clinical outcome to the corneal endothelium. Phacoemulsification 
was claimed to be more traumatized to the endothelium compared to the two previous 
techniques. Sugar et al in 1978 studied the mean endothelial density using specular 
microscopy in 86 patients who undergone phacoemulsification and intracapsular 
cataract extractions. Cataract extraction by the phacoemulsification appeared to be 
more traumatic (mean cell loss of 33.8%) to the endothelium than intracapsular 
extraction (mean cell loss of 14.9%). 
t 
A contradictory finding however was recently published. Bourne et a1 in 2004 
examined 500 patients, age 40 years and older who had undergone 
phacoemulsification or extracapsular cataract extraction with posterior chamber lens 
implantation. They assessed the mean cell loss, coefficient of variation and 
hexagonality in both groups preoperatively and up to one year postoperatively. They 
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found generally, there was no significant difference in both surgical techniques, 
though phacoemulsification carried a higher risk of cell loss in patients with hard 
nucleus and vitreous loss. This changing trend could be explained with regards to 
improvements in skills, techniques and instruments during phacoemulsification 
nowadays. 
Hayashi et al in 1996 conducted a study to determine the principal risk factors for 
corneal endothelial injury during phacoemulsification. They investigated 859 eyes of 
patients who had undergone phacoemulsification surgery. The percentage of corneal 
endothelial cell loss was quantified using specular microscopy. They found that the 
firmness of the nucleus was the most significant risk factor compared to other factors 
including older age group, small pupil diameter, large nucleus, greater infusion 
volume, type of intraocular lens implanted and ultrasound time. 
Shorter eye, especially with shallow anterior chamber is at risk of being traumatized 
during phacoemulsification. This had been confirmed by Walkow et a1 (2000) who 
found significant amount of endothelial. loss in eyes with shorter axial length. A 
possible explanation of this fact could be relate<! to the mean distance from the phaco 
tip and the cornea. Thus, phaco tip that was nearer to the endothelium would cause 
more degree of endothelial loss. 
Site of wound incision also influence the severity of endothelial loss. Amon et al in 
l995 found a difference in endothelial cell loss between a 3.5 nun superior scleral 
16 
tunnel incision (3.0%) and a 3.5 nun temporal clear corneal incision (8.1 %). This was 
probably because the scleral tunnel incision was placed more posterior and therefore 
induced less endothelial trauma. Thus, they recommended avoiding clear corneal 
incisions in eyes with very hard cataracts and pre-existing low cell density. 
The wound size is also another confounding factor of endothelial loss during 
phacoemulsification surgery. Dick et al (1996) studied the percentage of endothelial 
loss after implanting intraocular lens through 3.5mm and 5.5 mm wound incision. 
They found that phacoemulsification with 3.5 mm corneal incisions produced slightly 
less cell loss (6.7%) than phacoemulsification with 5.0 mm incisions (7.9%) at one 
year after the surgery. 
The techniques chosen during phacoemulsification surgery also influence the degree 
of endothelial cell loss. Kohlaas et al (1998) found that endothelial cell loss was also 
dependent on the surgical phacoemulsification technique. 10% endothelial cell loss 
was noted in 'phaco and chop' technique compared to 15% cell loss in 'divide and 
conquer technique'. 
( 
The time and power of the ultrasound are also claimed to be related to endothelial 
loss during phacoemulsification surgery. Dick et al in 1996 demonstrated a direct 
linear relationship between endothelial cell loss and ultrasound time and power; 
endothelial loss increased as the ultrasound time and power increased. They found 
that after one year, endothelial cell loss was 4.2% with ultrasound time less than 1 Y2 
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minutes, 6.7% with ultrasound time between I Y2 to 2Yl minutes and 9.6% with 
ultrasound time between 2 Y2 and 3 Y2 minutes. 
Dick et al (1996) also revealed that the percentage of endothelial cell loss was directly 
related to the ultrasound power. The endothelial cell loss was 4.1% with ultrasound 
power less than 10%, 6. 7% with ultrasound power between 11-20%, 8.0% with 
ultrasound power between 21-30% and 9.5% when ultrasound power more than 31% 
after one year follow-up. 
Intraocular lens implantation also causes a significant amount of endothelial loss. 
This loss of endothelium could be due to mainly contact between the intraocular lens 
and the endothelium during injection or unfolding. Irvine et al (1978) studied the 
effect to the corneal endothelium after phacoemulsification with and without 
intraocular lens implantation. The cell loss was documented as high as 26% with 
intraocular lens implantation, compared to 18% with phacoemulsification alone. 
The other possibility is that, lacking of adhesion between the posterior chamber 
intraocular lens (plate-haptic) and the lens capsule which was noted in silicone type 
of intraocular lens. Kraff et al in 1980 demonstrated that the most likely explanation 
for the above mechanism was 'iris shaving phenomenon' and this, subsequently 
caused chronic uveitis and further damage the corneal endothelium 
Type of intraocular lens is also another subject of debate among the ophthalmologists 
world wide regarding the amount of cell loss. Kassar et al (1980) studied the effect of 
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contact between silicone and polymethylmethacrylate (PMMA) lenses to the corneal 
endothelium in the animal models. They found that the silicone intraocular lenses 
provoked less endothelial loss than PMMA lenses. 
With further improvement of surgical skills and instrumentation, Oshika et al in 1994 
reported a contradictory result. They demonstrated that both silicone and PMMA 
lenses had no significant difference of endothelial cell loss. They compared 155 
patients who were randomly assigned between silicone intraocular lens implantation 
through a 3.2 mm incision and polymethylmethacrylate intraocular lens implantation 
through a 5.5 mm incision phacoemulsification surgery. 
Placement of intraocular lens is also another confounding factor in endothelial cell 
loss. This was demonstrated by Matsuda et al (1988) who studied the endothelial cell 
loss in different place of intraocular lens implantation after phacoemulsification. They 
found that 18.1% cell loss in scleral fixated lens, 23.5% cell loss in posterior chamber 
lens (with intact posterior capsule) and 28.5% cell loss in anterior chamber lens 
(ruptured posterior capsule) at three years after the surgery. 
( 
Regardless all the above risk factors, the surgeons' skills are still the main 
confounding factor in determining the success of the surgery. This includes their 
preferred method, how they manipulate the instruments and what phacoemulsification 
technique they use. These factors are also important parameters that would contribute 
to the outcome of phacoemulsification surgery. 
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1.4 QUANTITATIVE MEASUREMENT OF CORNEAL ENDOTHELIUM 
Specular microscope is an instrument to examine the endothelial cells. It uses 
specular reflection from the interface of the endothelial cells and aqueous humor. It 
enables us to study the changes occurring at different layers of cornea in various 
anterior segment disorders at much higher magnification. 
Since its invention 25 years ago by Maurice in 1968, many technological advances 
have been made in the design and applications of this technique. Currently with the 
modem specular microscopes, endothelial images can be digitally captured and 
automated morphometric analysis of endothelial cells can be done. 
Measurement of corneal endothelium can be performed by either contact or non-
contact specular microscope. In both cases, the instruments are designed to separate 
the illumination and viewing light. This allows us to view the very weak reflection 
from the endothelial cells surface despite reflection from the anterior corneal surface. 
!sager et al (2000) compared a contact (Konan Clinical Specular Microscope) and a ( 
non-contact specular microscope {Topcon SP-1 000) in the detennination of 
endothelial cell density. He showed that the average endothelial cell density and 
precision of both instruments were similar. Furthermore, the endothelial densities 
estimated by the two instruments at various values of anterior central corneal 
refractive power and central corneal thickness were also noted to be similar. Thus, 
they suggested that the two instruments could be used interchangeably. 
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There are few advantages of non-contact specular microscopy, for example it is 
convenient to use, atraumatized, carries less risk of infection and less time consuming 
as compared to contact specular microscopy. On the other hand, the advantage of 
using a contact specular microscope was better appreciated when examining a 
diseased cornea. 
This was demonstrated by Hara et al (2003) who compared the clinical efficacy 
between contact and non-contact specular microscope. They were able to obtain clear 
images in healthy corneas using both type of specular microscope. However in 
diseased cornea for example Fuchs's endothelial dystrophy, clear images were 
obtained only by contact type of specular microscope. 
Doughty et al (2000) had assessed the reliability of endothelial cell density estimates 
using a non-contact specular microscopy. They found that the reliability of the 
measurement depends greatly on the number of cells being studied. The reliability of 
cell density estimation was expected within ± 10% if only 25 cells were measured. 
However, the reliability improved to± 2% if75 cells were measured. 
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1.5 OPHTHALMIC VISCOELASTIC DEVICES 
It is a great advantage to maintain anterior chamber depth when performing cataract 
extraction by phacoemulsification combined with intraocular lens implantation. To 
achieve this stability, viscous substances are injected into the anterior chamber. The 
introduction of ophthalmic viscosurgical devices (OVDs) more than 20 years ago 
substantially improved the efficacy and safety of cataract surgery and intraocular lens 
implantation. 
A variety of ophthalmic viscosurgical devices are now available and each posses 
specific chemical and physical properties leading to different intraoperative 
behaviour. The change from extracapsular cataract extraction to phacoemulsification 
in recent years has placed new demands on the performance of viscoelastic devices. 
During phacoemulsification, endothelial injury can result from touch by lens matter 
or instruments, fluids movement and oxygen free radicals released during ultrasound. 
Thus, the principal tasks of these viscoelastic devices are mainly to protect the 
corneal endothelium from the above injurie~ and maintain depth of the anterior 
chamber throughout the procedure. 
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1.5.1 PROPERTIES OF OPHTHALMIC VISCOSURGICAL DEVICES 
The contents of currently available viscoelastic devices are based on three main 
chemical composition; that are hydroxypropyl methylcellulose (HPMC), chondroitin 
sulfate and sodium hyaluronate. These different materials actually exhibit different 
properties, in term of shear rate, viscosity, pseudoplasticity, elasticity and cohesion. 
Viscosity is a measure of the thickness of a solution. It is actually the property of a 
solution that resists the displacement of two adjacent layers between which it is 
sandwiched. This resistance to the displacement is however not constant. Thus, a 
needed force will vary depending on the speed at which the two surfaces move 
relative to each other. This velocity is called shear rate. 
Viscosity at zero shear rate means the viscosity at rest. It depicts the ability of a 
viscoelastic device to create anterior chamber depth, which ensures that the 
intraocular tissues are protected from trauma during surgery. 
High shear rates are usually reached during lliitial injection of viscoelastic device. 
The initial resistance is therefore perceptibly high because of high zero shear rate. 
Once the plunger starts to move, viscosity of the viscoelastic device decreases as a 
result of higher shear rate. This will allow the viscoelastic device to be injected with 
little energy expenditure. 
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Pseudoplasticity is defined as a quotient of two different viscosities at two different 
shear rates. Pseudoplasticity of a solution describes the decrease in viscosity with 
increasing shear rate, similar to high-flow situations. This property allows easier 
viscoelastic device injection through a cannula. 
Elasticity is the tendency of a material to return to its original shape after stretching, 
compression or deformation. Cohesion refers to the tendency of a viscoelastic device 
to resist breaking up and to flow as a unit. 
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